Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: Preliminary results

Diabetes, Obesity and Metabolism

Volumn 12, Issue 11, 2010, Pages 994-1003

  Hirsch, D ^a   Odorico, J ^a   Radke, N ^a   Hanson, M ^a   Danobeitia, J S ^a   Hullett, D ^a   Alejandro, R ^b,c   Ricordi, C ^c   Fernandez, L A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Glucose metabolism; Insulin resistance; Insulin secretion; PIT

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 2 DERIVATIVE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LEAN BODY WEIGHT; MALE; PANCREAS ISLET TRANSPLANTATION; SEX DIFFERENCE;

EID: 77957280701     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01290.x     Document Type: Article

References (40)

1. Shapiro AM, Ricordi C, Hering BJ. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318-1330..
2. Ryan EA, Paty BW, Senior PA. Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060-2069..
3. Alejandro R, Barton FB, Hering BJ, Wease S. Update from the Collaborative Islet Transplant Registry. Transplantation 2008, 86:1783-1788..
4. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981, 68:1456-1467..
5. DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 1982, 31:795-801..
6. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 2002, 18:192-200..
7. Pang TT, Narendran P. Addressing insulin resistance in Type 1 diabetes. Diabet Med 2008, 25:1015-1024..
8. Yki-Jarvinen H, Koivisto VA. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986, 315:224-230..
9. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004, 47:1661-1667..
10. Orchard TJ, Olson JC, Erbey JR. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003, 26:1374-1379..
11. Soedamah-Muthu SS, Chaturvedi N, Toeller M. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004, 27:530-537..
12. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: " double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 2007, 30:707-712..
13. Carlson LA. Antilipolysis as a tool in the study of clinical and experimental diabetes. Lecture for the 1968 Minkowski Award. Diabetologia 1969, 5:361-365..
14. Shapiro AM, Lakey JR, Ryan EA. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238..
15. Fernandez LA, Lehmann R, Luzi L. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999, 68:1532-1541..
16. Quon MJ, Cochran C, Taylor SI, Eastman RC. Direct comparison of standard and insulin modified protocols for minimal model estimation of insulin sensitivity in normal subjects. Diabetes Res 1994, 25:139-149..
17. Coates PA, Luzio SD, Brunel P, Owens DR. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 1995, 44:631-635..
18. Luzi L, Facchini F, Secchi A. Glucose metabolism in patients after combined kidney-pancreas transplantation. Transplant Proc 1990, 22:661..
19. Luzi L, Hering BJ, Socci C. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996, 97:2611-2618..
20. Saad MF, Anderson RL, Laws A. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 1994, 43:1114-1121..
21. Sumner AE, Bergman RN, Vega GL. The multiphasic profile of free fatty acids during the intravenous glucose tolerance test is unresponsive to exogenous insulin. Metabolism 2004, 53:1202-1207..
22. Boston RC, Moate PJ. A novel minimal model to describe NEFA kinetics following an intravenous glucose challenge. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1140-R1147..
23. Rickels MR, Naji A, Teff KL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab 2006, 91:2138-2144..
24. Moran A, Jacobs DR, Steinberger J. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999, 48:2039-2044..
25. McLachlan KA, Boston R, Alford FP. Impaired non-esterified fatty acid suppression to intravenous glucose during late pregnancy persists postpartum in gestational diabetes: a dominant role for decreased insulin secretion rather than insulin resistance. Diabetologia 2005, 48:1373-1379..
26. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 1980, 255:4758-4762..
27. Suzuki K, Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A 1980, 77:2542-2545..
28. Thorn LM, Forsblom C, Fagerudd J. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005, 28:2019-2024..
29. Welch S, Gebhart SS, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990, 71:1508-1518..
30. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002, 62:963-970..
31. Luzi L, Secchi A, Facchini F. Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients. Diabetologia 1990, 33:549-556..
32. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 1999, 96:513-523..
33. Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985, 28:119-121..
34. Luzi L. Metabolic strategies to predict and improve intrahepatic islet graft function. J Mol Med 1999, 77:49-56..
35. Yki-Jarvinen H, Helve E, Koivisto VA. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 1987, 36:892-896..
36. Kahn SE, Klaff LJ, Schwartz MW. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 1990, 71:994-1002..
37. Finegood DT, Hramiak IM, Dupre J. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990, 70:1538-1549..
38. Kahn SE, Beard JC, Schwartz MW. Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 1989, 38:562-568..
39. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998, 14:263-283..
40. Groop LC, Ferrannini E. Insulin action and substrate competition. Baillieres Clin Endocrinol Metab 1993, 7:1007-1032..